You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study

 

Online download statistics by month:

Online download statistics by month: June 2020 to January 2026

AbstractFullPdf
Jun 2020333314
Jul 2020348347188
Aug 202012913054
Sep 202012112162
Oct 2020787871
Nov 20209292107
Dec 2020606069
Jan 2021666657
Feb 202110210255
Mar 2021929046
Apr 2021686837
May 2021808037
Jun 2021494922
Jul 2021686832
Aug 202112512569
Sep 202113913970
Oct 2021797975
Nov 2021929269
Dec 202112312766
Jan 2022767837
Feb 2022394224
Mar 202210410453
Apr 202210911859
May 202210010257
Jun 2022869029
Jul 2022596227
Aug 2022696944
Sep 2022818157
Oct 2022868637
Nov 2022808263
Dec 2022505223
Jan 2023414121
Feb 2023848441
Mar 2023858632
Apr 2023535333
May 2023656533
Jun 2023454627
Jul 2023505124
Aug 2023535419
Sep 2023535322
Oct 2023818118
Nov 2023686822
Dec 2023545414
Jan 2024414222
Feb 2024777822
Mar 2024666630
Apr 2024434431
May 2024636324
Jun 2024606130
Jul 202410510830
Aug 2024595927
Sep 2024444429
Oct 2024535343
Nov 2024474836
Dec 2024495136
Jan 2025666749
Feb 202510110143
Mar 2025818168
Apr 2025909053
May 2025808148
Jun 2025363615
Jan 2026110
Total477748222652